Revatis S.A. • Technologies • Production of autologous stem cells for immediate or deferred clinical use
This is a muscle microbiopsy obtained with a fine biopsy needle. The microbiopsy performed by the veterinarian is sent to Revatis, which produces a batch of autologous stem cells.
Production of clinical batches of stem cells for autologous use
Production is carried out in an aseptic isolator meeting GMP standards with high quality control to ensure the characteristics of the stem cells for therapeutic use.
Simple, safe and minimally invasive technology
This approach allows treating veterinarians to offer owners the banking of stem cells for deferred clinical use.
Performing controlled clinical studies
Revatis complies with the rules published by the agencies for the development of innovative cell-based drugs in order to obtain marketing authorizations. However, within the framework of veterinary clinics, exemptions exist to use cell therapy in special cases.
Locomotory disorders in horses
These are the main causes of retirement as the usual treatments are not very effective. Regenerative medicine and cell therapy bring hope for full recovery. Optimal functional recovery also allows the horse a more comfortable existence.
Optimal functional recovery gives the horse a better comfort of life.
Stem cells production
To ensure optimal treatment in case of injuries, have your horses collected by your veterinarian and entrust Revatis with the production of stem cells for immediate or deferred clinical use.